Opioid-Induced Constipation Market Report

Global Opioid-Induced Constipation Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Jun 04, 2021
  • PAGES：223
  • REPORT CODE：GMM696126
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.

    The Opioid-Induced Constipation Market is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Opioid-Induced Constipation market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Opioid-Induced Constipation industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Opioid-Induced Constipation Market Segmentations:

    By Players:

    • Nektar Therapeutics

    • Salix (Bausch Health)

    • GSK

    • Takeda Pharmaceuticals

    • Mallinckrodt

    • Sanofi

    • AstraZeneca

    • Prestige

    • Bayer

    • Shionogi

    • Purdue Pharm

    • Daiichi Sankyo

    • Progenics Pharmaceuticals

    By Types:

    • Methylnaltrexone Bromide

    • Lubiprostone

    • Naloxegol

    • Others

    By End-User:

    • Hospital

    • Pharmacy

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Opioid-Induced Constipation Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Opioid-Induced Constipation Market Size and Growth Rate of Methylnaltrexone Bromide from 2014 to 2026

      • 1.3.2 Global Opioid-Induced Constipation Market Size and Growth Rate of Lubiprostone from 2014 to 2026

      • 1.3.3 Global Opioid-Induced Constipation Market Size and Growth Rate of Naloxegol from 2014 to 2026

      • 1.3.4 Global Opioid-Induced Constipation Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Opioid-Induced Constipation Market Size and Growth Rate of Hospital from 2014 to 2026

      • 1.4.2 Global Opioid-Induced Constipation Market Size and Growth Rate of Pharmacy from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Opioid-Induced Constipation Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Opioid-Induced Constipation Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Opioid-Induced Constipation by Major Types

      • 3.4.1 Opioid-Induced Constipation Market Size and Growth Rate of Methylnaltrexone Bromide

      • 3.4.2 Opioid-Induced Constipation Market Size and Growth Rate of Lubiprostone

      • 3.4.3 Opioid-Induced Constipation Market Size and Growth Rate of Naloxegol

      • 3.4.4 Opioid-Induced Constipation Market Size and Growth Rate of Others

    4 Segmentation of Opioid-Induced Constipation Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Opioid-Induced Constipation by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Opioid-Induced Constipation in Hospital

      • 4.4.2 Market Size and Growth Rate of Opioid-Induced Constipation in Pharmacy

    5 Market Analysis by Major Regions

    • 5.1 Global Opioid-Induced Constipation Production Analysis by Major Regions

    • 5.2 Global Opioid-Induced Constipation Consumption Analysis by Major Regions

    • 5.3 Global Opioid-Induced Constipation Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Opioid-Induced Constipation Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Opioid-Induced Constipation Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Opioid-Induced Constipation Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Opioid-Induced Constipation Production, Import, Consumption and Export Analysis

    6 Product Commodity of Opioid-Induced Constipation Market in Major Countries

    • 6.1 Top 5 Export Countries in Opioid-Induced Constipation market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Opioid-Induced Constipation market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Opioid-Induced Constipation market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Opioid-Induced Constipation market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Opioid-Induced Constipation market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Opioid-Induced Constipation market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Opioid-Induced Constipation Landscape Analysis

    • 7.1 North America Opioid-Induced Constipation Landscape Analysis by Major Types

    • 7.2 North America Opioid-Induced Constipation Landscape Analysis by Major End-Users

    • 7.3 North America Opioid-Induced Constipation Landscape Analysis by Major Countries

      • 7.3.1 United States Opioid-Induced Constipation Market Volume and Growth Rate

      • 7.3.2 Canada Opioid-Induced Constipation Market Volume and Growth Rate

      • 7.3.3 Mexico Opioid-Induced Constipation Market Volume and Growth Rate

    8 Europe Opioid-Induced Constipation Landscape Analysis

    • 8.1 Europe Opioid-Induced Constipation Landscape Analysis by Major Types

    • 8.2 Europe Opioid-Induced Constipation Landscape Analysis by Major End-Users

    • 8.3 Europe Opioid-Induced Constipation Landscape Analysis by Major Countries

      • 8.3.1 Germany Opioid-Induced Constipation Market Volume and Growth Rate

      • 8.3.2 UK Opioid-Induced Constipation Market Volume and Growth Rate

      • 8.3.3 France Opioid-Induced Constipation Market Volume and Growth Rate

      • 8.3.4 Italy Opioid-Induced Constipation Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Opioid-Induced Constipation Market Volume and Growth Rate

      • 8.3.6 Spain Opioid-Induced Constipation Market Volume and Growth Rate

      • 8.3.7 Belgium Opioid-Induced Constipation Market Volume and Growth Rate

      • 8.3.8 Poland Opioid-Induced Constipation Market Volume and Growth Rate

      • 8.3.9 Russia Opioid-Induced Constipation Market Volume and Growth Rate

      • 8.3.10 Turkey Opioid-Induced Constipation Market Volume and Growth Rate

    9 Asia Pacific Opioid-Induced Constipation Landscape Analysis

    • 9.1 Asia Pacific Opioid-Induced Constipation Landscape Analysis by Major Types

    • 9.2 Asia Pacific Opioid-Induced Constipation Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Opioid-Induced Constipation Landscape Analysis by Major Countries

      • 9.3.1 China Opioid-Induced Constipation Market Volume and Growth Rate

      • 9.3.2 Japan Opioid-Induced Constipation Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Opioid-Induced Constipation Market Volume and Growth Rate

      • 9.3.4 India Opioid-Induced Constipation Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Opioid-Induced Constipation Market Volume and Growth Rate

      • 9.3.6 South Korea Opioid-Induced Constipation Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Opioid-Induced Constipation Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Opioid-Induced Constipation Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Opioid-Induced Constipation Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Opioid-Induced Constipation Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Opioid-Induced Constipation Market Volume and Growth Rate

      • 10.3.2 Brazil Opioid-Induced Constipation Market Volume and Growth Rate

      • 10.3.3 Nigeria Opioid-Induced Constipation Market Volume and Growth Rate

      • 10.3.4 South Africa Opioid-Induced Constipation Market Volume and Growth Rate 

      • 10.3.5 Argentina Opioid-Induced Constipation Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Nektar Therapeutics

      • 11.1.1 Nektar Therapeutics Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Salix (Bausch Health)

      • 11.2.1 Salix (Bausch Health) Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 GSK

      • 11.3.1 GSK Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Takeda Pharmaceuticals

      • 11.4.1 Takeda Pharmaceuticals Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Mallinckrodt

      • 11.5.1 Mallinckrodt Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Sanofi

      • 11.6.1 Sanofi Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 AstraZeneca

      • 11.7.1 AstraZeneca Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Prestige

      • 11.8.1 Prestige Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Bayer

      • 11.9.1 Bayer Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Shionogi

      • 11.10.1 Shionogi Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Purdue Pharm

      • 11.11.1 Purdue Pharm Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Daiichi Sankyo

      • 11.12.1 Daiichi Sankyo Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Progenics Pharmaceuticals

      • 11.13.1 Progenics Pharmaceuticals Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 104 Figures and 154 Tables)

    • Figure Product Picture

    • Figure Opioid-Induced Constipation Market Size and Growth Rate of Methylnaltrexone Bromide from 2014 to 2026

    • Figure Opioid-Induced Constipation Market Size and Growth Rate of Lubiprostone from 2014 to 2026

    • Figure Opioid-Induced Constipation Market Size and Growth Rate of Naloxegol from 2014 to 2026

    • Figure Opioid-Induced Constipation Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Opioid-Induced Constipation Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Global Opioid-Induced Constipation Market Size and Growth Rate of Pharmacy from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Opioid-Induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Opioid-Induced Constipation Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Opioid-Induced Constipation

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Opioid-Induced Constipation by Different Types from 2014 to 2026

    • Table Consumption Share of Opioid-Induced Constipation by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Methylnaltrexone Bromide

    • Figure Market Size and Growth Rate of Lubiprostone

    • Figure Market Size and Growth Rate of Naloxegol

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Opioid-Induced Constipation by Different End-Users from 2014 to 2026

    • Table Consumption Share of Opioid-Induced Constipation by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Pharmacy

    • Table Global Opioid-Induced Constipation Production by Major Regions

    • Table Global Opioid-Induced Constipation Production Share by Major Regions

    • Figure Global Opioid-Induced Constipation Production Share by Major Regions in 2014

    • Figure Global Opioid-Induced Constipation Production Share by Major Regions in 2018

    • Figure Global Opioid-Induced Constipation Production Share by Major Regions in 2026

    • Table Global Opioid-Induced Constipation Consumption by Major Regions

    • Table Global Opioid-Induced Constipation Consumption Share by Major Regions

    • Figure Global Opioid-Induced Constipation Consumption Share by Major Regions in 2014

    • Figure Global Opioid-Induced Constipation Consumption Share by Major Regions in 2018

    • Figure Global Opioid-Induced Constipation Consumption Share by Major Regions in 2026

    • Table North America Opioid-Induced Constipation Production, Import, Consumption and Export Analysis

    • Table Europe Opioid-Induced Constipation Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Opioid-Induced Constipation Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Opioid-Induced Constipation Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Opioid-Induced Constipation market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Opioid-Induced Constipation market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Opioid-Induced Constipation market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Opioid-Induced Constipation market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Opioid-Induced Constipation Consumption by Types from 2014 to 2026

    • Table North America Opioid-Induced Constipation Consumption Share by Types from 2014 to 2026

    • Figure North America Opioid-Induced Constipation Consumption Share by Types in 2014

    • Figure North America Opioid-Induced Constipation Consumption Share by Types in 2018

    • Figure North America Opioid-Induced Constipation Consumption Share by Types in 2026

    • Table North America Opioid-Induced Constipation Consumption by End-Users from 2014 to 2026

    • Table North America Opioid-Induced Constipation Consumption Share by End-Users from 2014 to 2026

    • Figure North America Opioid-Induced Constipation Consumption Share by End-Users in 2014

    • Figure North America Opioid-Induced Constipation Consumption Share by End-Users in 2018

    • Figure North America Opioid-Induced Constipation Consumption Share by End-Users in 2026

    • Table North America Opioid-Induced Constipation Consumption by Major Countries from 2014 to 2026

    • Table North America Opioid-Induced Constipation Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Opioid-Induced Constipation Consumption Share by Major Countries in 2014

    • Figure North America Opioid-Induced Constipation Consumption Share by Major Countries in 2018

    • Figure North America Opioid-Induced Constipation Consumption Share by Major Countries in 2026

    • Figure United States Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Opioid-Induced Constipation Consumption by Types from 2014 to 2026

    • Table Europe Opioid-Induced Constipation Consumption Share by Types from 2014 to 2026

    • Figure Europe Opioid-Induced Constipation Consumption Share by Types in 2014

    • Figure Europe Opioid-Induced Constipation Consumption Share by Types in 2018

    • Figure Europe Opioid-Induced Constipation Consumption Share by Types in 2026

    • Table Europe Opioid-Induced Constipation Consumption by End-Users from 2014 to 2026

    • Table Europe Opioid-Induced Constipation Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Opioid-Induced Constipation Consumption Share by End-Users in 2014

    • Figure Europe Opioid-Induced Constipation Consumption Share by End-Users in 2018

    • Figure Europe Opioid-Induced Constipation Consumption Share by End-Users in 2026

    • Table Europe Opioid-Induced Constipation Consumption by Major Countries from 2014 to 2026

    • Table Europe Opioid-Induced Constipation Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Opioid-Induced Constipation Consumption Share by Major Countries in 2014

    • Figure Europe Opioid-Induced Constipation Consumption Share by Major Countries in 2018

    • Figure Europe Opioid-Induced Constipation Consumption Share by Major Countries in 2026

    • Figure Germany Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure France Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Opioid-Induced Constipation Consumption by Types from 2014 to 2026

    • Table Asia Pacific Opioid-Induced Constipation Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Opioid-Induced Constipation Consumption Share by Types in 2014

    • Figure Asia Pacific Opioid-Induced Constipation Consumption Share by Types in 2018

    • Figure Asia Pacific Opioid-Induced Constipation Consumption Share by Types in 2026

    • Table Asia Pacific Opioid-Induced Constipation Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Opioid-Induced Constipation Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Opioid-Induced Constipation Consumption Share by End-Users in 2014

    • Figure Asia Pacific Opioid-Induced Constipation Consumption Share by End-Users in 2018

    • Figure Asia Pacific Opioid-Induced Constipation Consumption Share by End-Users in 2026

    • Table Asia Pacific Opioid-Induced Constipation Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Opioid-Induced Constipation Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Opioid-Induced Constipation Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Opioid-Induced Constipation Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Opioid-Induced Constipation Consumption Share by Major Countries in 2026

    • Figure China Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandOpioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure India Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Opioid-Induced Constipation Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Opioid-Induced Constipation Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Opioid-Induced Constipation Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Opioid-Induced Constipation Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Opioid-Induced Constipation Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Opioid-Induced Constipation Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation Consumption Share by Major Countries in 2026

    • Figure GCC Countries Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Opioid-Induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Nektar Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nektar Therapeutics

    • Figure Sales and Growth Rate Analysis of Nektar Therapeutics

    • Figure Revenue and Market Share Analysis of Nektar Therapeutics

    • Table Product and Service Introduction of Nektar Therapeutics

    • Table Company Profile and Development Status of Salix (Bausch Health)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Salix (Bausch Health)

    • Figure Sales and Growth Rate Analysis of Salix (Bausch Health)

    • Figure Revenue and Market Share Analysis of Salix (Bausch Health)

    • Table Product and Service Introduction of Salix (Bausch Health)

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Takeda Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceuticals

    • Table Product and Service Introduction of Takeda Pharmaceuticals

    • Table Company Profile and Development Status of Mallinckrodt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt

    • Figure Sales and Growth Rate Analysis of Mallinckrodt

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Product and Service Introduction of Mallinckrodt

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Prestige

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Prestige

    • Figure Sales and Growth Rate Analysis of Prestige

    • Figure Revenue and Market Share Analysis of Prestige

    • Table Product and Service Introduction of Prestige

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Shionogi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shionogi

    • Figure Sales and Growth Rate Analysis of Shionogi

    • Figure Revenue and Market Share Analysis of Shionogi

    • Table Product and Service Introduction of Shionogi

    • Table Company Profile and Development Status of Purdue Pharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharm

    • Figure Sales and Growth Rate Analysis of Purdue Pharm

    • Figure Revenue and Market Share Analysis of Purdue Pharm

    • Table Product and Service Introduction of Purdue Pharm

    • Table Company Profile and Development Status of Daiichi Sankyo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo

    • Figure Sales and Growth Rate Analysis of Daiichi Sankyo

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo

    • Table Product and Service Introduction of Daiichi Sankyo

    • Table Company Profile and Development Status of Progenics Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals

    • Table Product and Service Introduction of Progenics Pharmaceuticals


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US